The Center for Clinical and Translational Research was founded at Virginia Commonwealth University
In 2007, the Center for Clinical and Translational Research (CCTR) was founded at Virginia Commonwealth University to enhance…
R Paul Robertson received two NIDDK grants totaling to improve islet transplantation
In 2007, R. Paul Robertson, M.D., at the Pacific Northwest Research Institute, received two grants totaling $3,173,400 from…
Richard Nakamura, PhD, became the first Asian American scientific director of the National Institute of Mental Health
In 2007, Richard Nakamura, Ph.D., became the first Asian American scientific director of the National Institute of Mental…
Livermore Lab developed pathogen signatures for bioterrorist attack Identification
In 2007, researchers at Livermore National Laboratory announced they had developed candidate signatures for pathogens that might be…
Yale’s West Campus, located on 136 acres 7 miles west of downtown New Haven, was acquired
In 2007, West Campus, located on 136 acres 7 miles west of downtown New Haven, was acquired. West…
Lethal infection of K18-hACE2 mice infected with Severe Acute Respiratory Syndrome Coronavirus published
In January 2007, scientists at the University of Iowa reported in the Journal of Virology that they had…
Biotechnology | Diagnostics | Disease | FDA | Therapeutics
FDA approved Elelyso (taliglucerase alfa) for long-term enzyme replacement therapy to treat a form of Gaucher disease
In 2007, the U.S. Food and Drug Administration (FDA) approved Elelyso (taliglucerase alfa) for long-term enzyme replacement therapy…
Jordan Tang led a team of OMRF scientists that identified and cloned the enzyme believed to cause Alzheimer’s disease
In 2007, Dr. Jordan Tang, led a team of scientists at Oklahoma Medical Research Foundation (OMRF) that identified…
The Oregon Translational Research and Drug Discovery Institute at Oregon State University was founded
In 2007, The Oregon Translational Research and Drug Discovery Institute (OTRADI) at Oregon State University was established by…
Vanderbilt Center for Neuroscience Drug Discovery was founded
In 2007, the Vanderbilt Center for Neuroscience Drug Discovery was established, combining the expertise of four groups of…
The CDC responded to a multi-state outbreak of E coli infections
On Dec. 14, 2006, the U.S. Centers for Disease Control and Prevention (CDC) reported a multi-state outbreak of…
Washington University received its largest grant ever for the Genome Sequencing Center
On Nov. 20, 2006, the Genome Sequencing Center at Washington University School of Medicine in St. Louis announced…
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics | Women's Health
FDA approved trastuzumab for use with other drugs in adjuvant treatment of women with early-stage, node-positive, HER2-overexpressing breast cancer
On Nov. 16, 2006, the U.S. Food and Drug Administration (FDA) approved Genentech’s trastuzumab (Herceptin) for use with…
The FDA approved Glivec for Five Rare, Life-Threatening Disorders
On Oct. 19, 2006, the U.S. Food and Drug Administration (FDA) granted Glivec® (imatinib) has received US regulatory…
The FDA approved Gleevec for Five Rare, Life-Threatening Disorders
On Oct. 19, 2006, the U.S. Food and Drug Administration (FDA) approved the drug, Gleevec developed by Oregon…
ICOS Corp announced agreement to be acquired by Eli Lilly
On Oct. 18, 2006, ICOS announced it had signed an agreement to be acquired by Eli Lilly and…
Biotechnology | Diagnostics | Disease | Genomics | NIH | Oncology | Therapeutics | Women's Health
NIH announced two integral components of the Cancer Genome Atlas Pilot Project
On Oct. 16, 2006, the Cancer Genome Atlas program, created by National Cancer Institute and the National Human…
Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for translational research
On Oct. 10, 2006, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for…
National Cancer Institute scientists identified novel protein that ties disruption of critical cellular pathway to Birt-Hogg-Dub syndrome
On Oct 2, 2006, National Cancer Institute researchers have linked specific genetic mutations to defects in cells that…
The Allen Institute for Brain Science Completed the Brain Atlas
On Sept. 26, 2006, the Allen Institute for Brain Science announced the completion of the groundbreaking Allen Brain…
The OMRF celebrated it’s 60th anniversary
On Sept. 15, 2006, the Oklahoma Medical Research Foundation (OMRF) celebrated it’s 60th anniversary. More than 600 people…
National Cancer Institute researchers developed a new model for estimating the 5-year risk of melanoma
On Sept. 1, 2006, National Cancer Institute (NCI) researchers developed a new model for estimating the 5-year risk…
Sandia Center for Integrated Nanotechnologies facility (CINT) was dedicated
On Aug. 23, 2006, the Sandia Center for Integrated Nanotechnologies facility (CINT) was dedicated. Designed as a national…
Corus Pharma was acquired by Gilead Sciences for $365 million
On Aug. 11, 2006, Gilead Sciences announced that it had completed its acquisition of Corus Pharma for $365…
The Frances Langford Heart Center opened its doors
On Aug. 1, 2006, the Frances Langford Heart Center opened its doors bringing open-heart surgery and interventional cardiology…
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Therapeutics
Alaska Airlines awarded E. Donnall Thomas Medal of Achievement Medal
On Jul. 18, 2006, the Fred Hutchinson Business Alliance announced that the E. Donnall Thomas Medal of Achievement…
Eli Lilly and Company’s Gemzar was approved for use in the treatment of women living with recurrent ovarian cancer
On Jul. 17, 2006, Eli Lilly and Company’s Gemzar was approved by the U.S. Food and Drug Administration (FDA) for…
The U.S. Surgeon General released a report on the harmful health consequences of involuntary exposure to second-hand tobacco smoke
On Jun. 27, 2006, the U.S. Surgeon General released a report on the harmful health consequences of involuntary…
Personalized treatment trial for breast cancer was launched
On May 23, 2006, the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, was launched to examine…
Massey Cancer Center’s opened Goodwin Research Laboratory
On May 11, 2006, Massey Cancer Center’s opened Goodwin Research Laboratory, an 80,000-square-foot, state-of-the-art cancer research laboratory.